Ameriprise Financial Inc Argenx Se Transaction History

Ameriprise Financial Inc

$381 Billion
Q3 2024

A detailed history of Ameriprise Financial Inc transactions in Argenx Se stock. As of the latest transaction made, Ameriprise Financial Inc holds 6,374 shares of ARGX stock, worth $3.98 Million. This represents 0.0% of its overall portfolio holdings.

Number of Shares

6,374

Previous 1,720 270.58%

Holding current value

$3.98 Million

Previous $739,000 367.66%

% of portfolio

0.0%

Previous 0.0%

21 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 14, 2024	BUY	$434.22 - $551.9 $2.02 Million - $2.57 Million	4,654 Added 270.58%	6,374 $3.46 Million
Q2 2024 Aug 14, 2024	BUY	$356.01 - $451.55 $51,621 - $65,474	145 Added 9.21%	1,720 $739,000
Q1 2024 May 15, 2024	BUY	$356.95 - $413.29 $83,883 - $97,123	235 Added 17.54%	1,575 $620,000
Q4 2023 Feb 14, 2024	SELL	$338.91 - $506.01 $7,456 - $11,132	-22 Reduced 1.62%	1,340 $509,000
Q3 2023 Nov 14, 2023	SELL	$369.35 - $548.43 $738 - $1,096	-2 Reduced 0.15%	1,362 $669,000
Q2 2023 Aug 14, 2023	BUY	$360.14 - $422.58 $7,562 - $8,874	21 Added 1.56%	1,364 $531,000
Q1 2023 May 15, 2023	SELL	$334.23 - $403.65 $8.56 Million - $10.3 Million	-25,609 Reduced 95.02%	1,343 $500,000
Q4 2022 Feb 14, 2023	SELL	$342.17 - $402.31 $3.49 Million - $4.11 Million	-10,210 Reduced 27.47%	26,952 $10.2 Million
Q3 2022 Nov 14, 2022	SELL	$343.2 - $395.75 $27.2 Million - $31.4 Million	-79,223 Reduced 68.07%	37,162 $13.1 Million
Q2 2022 Aug 15, 2022	SELL	$269.58 - $378.88 $51.3 Million - $72 Million	-190,124 Reduced 62.03%	116,385 $44.1 Million
Q1 2022 May 16, 2022	SELL	$254.45 - $351.06 $14 Million - $19.3 Million	-54,961 Reduced 15.2%	306,509 $96.6 Million
Q4 2021 Feb 14, 2022	SELL	$272.01 - $353.03 $929,730 - $1.21 Million	-3,418 Reduced 0.94%	361,470 $127 Million
Q3 2021 Nov 15, 2021	SELL	$295.0 - $350.58 $1.07 Million - $1.27 Million	-3,626 Reduced 0.98%	364,888 $110 Million
Q2 2021 Aug 16, 2021	SELL	$257.11 - $319.92 $962,362 - $1.2 Million	-3,743 Reduced 1.01%	368,514 $111 Million
Q1 2021 May 17, 2021	SELL	$268.3 - $380.31 $15.9 Million - $22.6 Million	-59,372 Reduced 13.76%	372,257 $103 Million
Q4 2020 Feb 12, 2021	SELL	$248.13 - $308.36 $26.3 Million - $32.7 Million	-106,104 Reduced 19.73%	431,629 $127 Million
Q3 2020 Nov 16, 2020	BUY	$215.51 - $272.51 $20.5 Million - $26 Million	95,273 Added 21.53%	537,733 $141 Million
Q2 2020 Aug 14, 2020	BUY	$127.44 - $232.72 $2.41 Million - $4.41 Million	18,932 Added 4.47%	442,460 $99.7 Million
Q1 2020 May 15, 2020	SELL	$108.83 - $165.23 $10 Million - $15.2 Million	-91,947 Reduced 17.84%	423,528 $55.8 Million
Q4 2019 Feb 14, 2020	BUY	$106.59 - $164.21 $11.2 Million - $17.3 Million	105,320 Added 25.68%	515,475 $82.7 Million
Q3 2019 Nov 14, 2019	BUY	$113.31 - $150.51 $46.5 Million - $61.7 Million	410,155 New	410,155 $46.7 Million

Others Institutions Holding ARGX

# of Institutions

400

Shares Held

30.9M

Call Options Held

376K

Put Options Held

489K

View Full List

About ARGENX SE

Ticker ARGX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 55,323,800
Market Cap $34.5B
Description
argenx SE, a biotechnology company, focuses on developing various therapies for the treatment of autoimmune diseases in the United States, the Netherlands, Belgium, Japan, Switzerland, Germany and France. Its lead product candidate is efgartigimod for the treatment of patients with myasthenia gravis, immune thrombocytopenia, pemphigus vulgaris, ...

More about ARGX

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Ameriprise Financial Inc, based on Form 13F filings with the SEC.

News

Stay updated on Ameriprise Financial Inc with notifications on news.

Account

Ameriprise Financial Inc Argenx Se Transaction History